FR3143326B3 - Pharmaceutical or dietary composition comprising an extract of Hyphaene thebaica and an extract of Olea europaea usable as an antihypertensive and hypolipidemic agent. - Google Patents

Pharmaceutical or dietary composition comprising an extract of Hyphaene thebaica and an extract of Olea europaea usable as an antihypertensive and hypolipidemic agent. Download PDF

Info

Publication number
FR3143326B3
FR3143326B3 FR2213740A FR2213740A FR3143326B3 FR 3143326 B3 FR3143326 B3 FR 3143326B3 FR 2213740 A FR2213740 A FR 2213740A FR 2213740 A FR2213740 A FR 2213740A FR 3143326 B3 FR3143326 B3 FR 3143326B3
Authority
FR
France
Prior art keywords
extract
thebaica
hyphaene
antihypertensive
usable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2213740A
Other languages
French (fr)
Other versions
FR3143326A3 (en
Inventor
Mariem Zakraoui
Ahlam Outman
Bernard Gressier
Lamia Hamrouni
Eto Bruno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR2213740A priority Critical patent/FR3143326B3/en
Publication of FR3143326A3 publication Critical patent/FR3143326A3/en
Application granted granted Critical
Publication of FR3143326B3 publication Critical patent/FR3143326B3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L’invention concerne une nouvelle association d’un extrait aqueux du péricarpe dénudé du fruit d’Hyphaene thebaica (palmier doum) et un extrait de jeunes feuilles d’Olea europaea sous le nom d’IFANOSINE pour le traitement de l’hypertension artérielle ou l’hyperlipidémie, ladite association étant sous une forme adaptée pour une administration par voie orale.The invention relates to a new combination of an aqueous extract of the bare pericarp of the fruit of Hyphaene thebaica (doum palm) and an extract of young leaves of Olea europaea under the name IFANOSINE for the treatment of arterial hypertension or hyperlipidemia, said combination being in a form suitable for oral administration.

FR2213740A 2022-12-19 2022-12-19 Pharmaceutical or dietary composition comprising an extract of Hyphaene thebaica and an extract of Olea europaea usable as an antihypertensive and hypolipidemic agent. Active FR3143326B3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR2213740A FR3143326B3 (en) 2022-12-19 2022-12-19 Pharmaceutical or dietary composition comprising an extract of Hyphaene thebaica and an extract of Olea europaea usable as an antihypertensive and hypolipidemic agent.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2213740A FR3143326B3 (en) 2022-12-19 2022-12-19 Pharmaceutical or dietary composition comprising an extract of Hyphaene thebaica and an extract of Olea europaea usable as an antihypertensive and hypolipidemic agent.
FR2213740 2022-12-19

Publications (2)

Publication Number Publication Date
FR3143326A3 FR3143326A3 (en) 2024-06-21
FR3143326B3 true FR3143326B3 (en) 2025-04-11

Family

ID=91486425

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2213740A Active FR3143326B3 (en) 2022-12-19 2022-12-19 Pharmaceutical or dietary composition comprising an extract of Hyphaene thebaica and an extract of Olea europaea usable as an antihypertensive and hypolipidemic agent.

Country Status (1)

Country Link
FR (1) FR3143326B3 (en)

Also Published As

Publication number Publication date
FR3143326A3 (en) 2024-06-21

Similar Documents

Publication Publication Date Title
MA40814A1 (en) Pharmaceutical compositions for combination therapy
MA64509B1 (en) HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS
MA64121B1 (en) HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS
MA57908B1 (en) SUBSTITUTED MACROCYCLIC COMPOUNDS AND METHODS OF PROCESSING THEM
MA44851B1 (en) Amide substituted pyridinyltriazole derivatives and their uses
AR035001A1 (en) PHARMACEUTICAL COMPOSITIONS OF ORAL ADMINISTRATION, CONTAINING A GASTROINTESTINAL LIPASE INHIBITOR, THE MASSAGE TABLETS AND THE USE OF SUCH COMPOUNDS TO PREPARE A MEDICINAL PRODUCT
EP4349839A3 (en) Tricyclic akr1c3 dependent kars inhibitors
MA35513B1 (en) Pharmaceutical compositions comprising 40 - o - (2 - hydroxy) ethyl - rapamycin
MA39040A1 (en) New combination therapy for acute myeloid leukemia (AML)
MA46490A1 (en) Substituted 4'- fluoro-2 '- methyl nucleoside derivatives
EP1753777A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION USING TRIM5a
BR112019025214A2 (en) SOLID PHARMACEUTICAL COMPOSITION ADMINISTRATIBLE ORALLY, USE OF THE PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING A PATIENT SUFFERING FROM PATHOLOGICAL CONDITIONS
MA54522A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
MA43960B1 (en) C-3 and c-17 modified triterpenoids used as inhibitors of hiv-1
FR3143326B3 (en) Pharmaceutical or dietary composition comprising an extract of Hyphaene thebaica and an extract of Olea europaea usable as an antihypertensive and hypolipidemic agent.
NO20054441L (en) G-lactam derivatives as prostaglandin agonists
MA26982A1 (en) 2H-1-BENZOPYRAN DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS IN WHICH THEY ARE USED.
MA53372B1 (en) Pyridopyrimidinenes as histamine h4 receptor inhibitors
EP4640222A3 (en) NEW COMPOSITION OF GASTRODIA ELATA, CITICOLIN, L-ACETYLCARNITIN AND VITAMIN D
MA34730B1 (en) ORALLY ADMINISTERING PHARMACEUTICAL COMPOSITION AND PROCESS FOR PREPARING THE SAME WITH INTESTINAL MOTILITY MODIFIER AND A-D-GALAGTOSIDASE USING THE SAME FOR THE PREVENTION AND TREATMENT OF IRRITABLE INTESTIN SYNDROME
BRPI0504117A (en) epitopes, combination of epitopes, uses of epitopes or their combination, composition, uses of composition, anti-HIV-1 prophylactic vaccines, therapeutic vaccines, method for identifying epitopes and methods for treatment or prevention.
BR112021018222A2 (en) Composition
EP3777849A4 (en) PHARMACEUTICAL COMPOSITION, COMPRISING POLMACOXIB AND PREGABALIN, FOR THE TREATMENT OF PAIN
EP4285901A4 (en) COMPOSITE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A BRAIN DISEASE, COMPRISING A CHOLINESTERASE INHIBITOR AND AN ANTIOXIDANT
MA44769B1 (en) Formulations for use in the treatment or prevention of urological diseases

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4